Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Ionis Pharmaceuticals Inc (NASDAQ: IONS) closed at $32.90 in the last session, down -1.53% from day before closing price of $33.41. In other words, the price has decreased by -$1.53 from its previous closing price. On the day, 1.79 million shares were traded. IONS stock price reached its highest trading level at $33.84 during the session, while it also had its lowest trading level at $32.69.
Ratios:
We take a closer look at IONS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.43 and its Current Ratio is at 8.47. In the meantime, Its Debt-to-Equity ratio is 3.33 whereas as Long-Term Debt/Eq ratio is at 3.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on August 02, 2024, Downgraded its rating to Market Perform and sets its target price to $60 from $67 previously.
On July 24, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $53 to $62.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 11 ’25 when Monia Brett P sold 140 shares for $32.32 per share. The transaction valued at 4,525 led to the insider holds 180,980 shares of the business.
Monia Brett P bought 140 shares of IONS for $4,525 on Mar 11 ’25. On Feb 20 ’25, another insider, O’NEIL PATRICK R., who serves as the EVP CLO & General Counsel of the company, sold 1,207 shares for $32.35 each. As a result, the insider received 39,046 and left with 56,245 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IONS now has a Market Capitalization of 5229948416 and an Enterprise Value of 4885803008. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.41 while its Price-to-Book (P/B) ratio in mrq is 8.83. Its current Enterprise Value per Revenue stands at 6.929 whereas that against EBITDA is -10.55.
Stock Price History:
The Beta on a monthly basis for IONS is 0.24, which has changed by -0.22679204 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, IONS has reached a high of $52.34, while it has fallen to a 52-week low of $30.23. The 50-Day Moving Average of the stock is -0.02%, while the 200-Day Moving Average is calculated to be -17.02%.
Shares Statistics:
According to the various share statistics, IONS traded on average about 1.68M shares per day over the past 3-months and 1813600 shares per day over the past 10 days. A total of 157.91M shares are outstanding, with a floating share count of 154.56M. Insiders hold about 2.77% of the company’s shares, while institutions hold 100.65% stake in the company. Shares short for IONS as of 1740700800 were 12853622 with a Short Ratio of 7.64, compared to 1738281600 on 12124536. Therefore, it implies a Short% of Shares Outstanding of 12853622 and a Short% of Float of 9.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
